BioCorRx Inc. (BICX)
Provides addiction treatment programs and develops long-acting naltrexone medications for substance use disorders.
$0.30+0.20%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-37.2%
The outlook
BICX trades near its 52-week low, sitting well below both its 50- and 200-day moving averages. Analyst coverage appears thin, and the overall data lean is bearish. The stock's current position suggests it remains in a weak technical state relative to recent history.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range9% of the way from its 52-week low to high
Market cap
$8.7M
52-wk high
$1.28
52-wk low
$0.20
50-day avg
$0.35
200-day avg
$0.36
Trailing P/E
—